Evidence map›Paper›PMID 35260896›Full record

ArticlePediatrics2022

School Masking Policies and Secondary SARS-CoV-2 Transmission.

Angelique E Boutzoukas, Kanecia O Zimmerman, Moira Inkelas, M Alan Brookhart, Daniel K Benjamin, Sabrina Butteris, Shawn Koval, Gregory P DeMuri, Vladimir G Manuel, Michael J Smith and 12 more

Open access · greenAbstract read
In one paragraph

Article in Pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Measures implemented in the school setting to contain the COVID-19 pandemic.The Cochrane database of systematic reviews · 2024
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Effect of Face Masking on Transmission of SARS-CoV-2.Advances in experimental medicine and biology · 2024
    Article
  15. Article
  16. Does equipoise exist for masking children for COVID-19?Public health in practice (Oxford, England) · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 1 country.

Angelique E BoutzoukasDuke Clinical Research Institute.
Kanecia O ZimmermanDuke Clinical Research Institute.
Moira InkelasFielding School of Public Health.
M Alan BrookhartPopulation Health Sciences, Duke University School of Medicine, Durham, North Carolina.
Daniel K BenjaminClemson University, Clemson, South Carolina.
Sabrina ButterisDepartment of Pediatrics, University of Wisconsin School of Medicine & Public Health, Maddison, Wisconsin.
Shawn KovalUniversity of Wisconsin Health, Healthy Kids Collaborative, Madison, Wisconsin.
Gregory P DeMuriDepartment of Pediatrics, University of Wisconsin School of Medicine & Public Health, Maddison, Wisconsin.
Vladimir G ManuelClinical and Translational Science Institute, University of California Los Angeles, Los Angeles, California.
Michael J SmithDepartments of Pediatrics.
Kathleen A McGannDepartments of Pediatrics.
Ibukunoluwa C KaluDepartments of Pediatrics.
David J WeberDivision of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, North Carolina.
Amy FalkDepartment of Pediatrics, Aspirus Doctors Clinic, Wisconsin Rapids, Wisconsin.
Andi L ShaneEmory University School of Medicine, Atlanta, Georgia.
Jennifer E SchusterDivision of Pediatric Infectious Diseases, Children's Mercy Kansas City, Kansas City, Missouri.
Jennifer L GoldmanDivision of Pediatric Infectious Diseases, Children's Mercy Kansas City, Kansas City, Missouri.
Jesse HickersonDuke Clinical Research Institute.
Vroselyn BenjaminDuke Clinical Research Institute.
Laura EdwardsDuke Clinical Research Institute.
Tyler R EricksonDuke Clinical Research Institute.
Daniel K BenjaminDuke Clinical Research Institute.
Clinical Research Institute · USChildren's Mercy Hospital · USAspirus · USDuke University · USEmory University · USUniversity of California, Los Angeles · USUniversity of California System · USUniversity of North Carolina at Chapel Hill · USUniversity of Wisconsin Health · US

Funding

RADx-UP SAY YES COVID Test Study (S4)U24MD016258 · NIMHD · DUKE UNIVERSITY · PI COHEN-WOLKOWIEZ, MICHAEL, DAVE, GAURAV J · 2020 to 2023
$116.7M
SARS-CoV-2 Screening and Diagnostic testing for return to K-12 schoolsOT2HD107559 · NICHD · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K., ZIMMERMAN, KANECIA OBIE · 2021 to 2022
$5.0M
Support for Safe Return to in-Person School: COVID-19 Testing, Learning, and Consultation (School TLC)OT2HD107555 · NICHD · ICF MACRO, INC. · PI GOLDMAN, JENNIFER LYNN, KEENER MAST, DANA · 2021 to 2022
$5.0M
Project Safe Schools: Re-opening schools SAFELY for Native American youthOT2HD107543 · NICHD · JOHNS HOPKINS UNIVERSITY · PI BARLOW, MARY ALLISON, HAMMITT, LAURA · 2021 to 2022
$4.8M
COV-IDD: Testing for COVID-19 in high risk children with intellectual and developmental disabilitiesOT2HD107553 · NICHD · UNIVERSITY OF ROCHESTER · PI DEWHURST, STEPHEN, FOXE, JOHN J · 2021 to 2022
$4.0M
Using COVID-19 testing and risk communication strategies to accelerate students return to schoolOT2HD107544 · NICHD · UNIVERSITY OF WASHINGTON · PI KO, LINDA K. · 2021 to 2022
$4.0M
Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved PopulationOT2HD107557 · NICHD · WASHINGTON UNIVERSITY · PI NEWLAND, JASON · 2021 to 2022
$4.0M
ReSET: Restarting Safe Education and Testing for Children with Medical ComplexityOT2HD107558 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI COLLER, RYAN J, DEMURI, GREGORY P · 2021 to 2022
$3.0M
Impact of COVID-19 testing and mitigation on equitable return-to-school in the second largest US school districtOT2HD108103 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI INKELAS, MOIRA, WONG, MITCHELL DAVID · 2021 to 2022
$3.0M
Unified Program for Therapeutics in Children (UPTiC)T32HD094671 · NICHD · DUKE UNIVERSITY · PI Ian J Davis, Kanecia Obie Zimmerman · 2019 to 2026
$2.9M
WUIDDRC and KKI Safe Return to SchoolOT2HD107556 · NICHD · WASHINGTON UNIVERSITY · PI GURNETT, CHRISTINA, KALB, LUTHER · 2021 to 2021
$2.7M
NICHD NIH HHS HHSN275201000003CNICHD NIH HHS HHSN275201000003INICHD NIH HHS OT2 HD107543NICHD NIH HHS OT2 HD107544NICHD NIH HHS OT2 HD107553NICHD NIH HHS OT2 HD107555NICHD NIH HHS OT2 HD107556NICHD NIH HHS OT2 HD107557NICHD NIH HHS OT2 HD107558NICHD NIH HHS OT2 HD107559NICHD NIH HHS OT2 HD108103NICHD NIH HHS T32 HD094671NIMHD NIH HHS U24 MD016258
6 · The paper itself

Abstract

objectivesThroughout the COVID-19 pandemic, masking has been a widely used mitigation practice in kindergarten through 12th grade (K-12) school districts to limit within-school transmission. Prior studies attempting to quantify the impact of masking have assessed total cases within schools; however, the metric that more optimally defines effectiveness of mitigation practices is within-school transmission, or secondary cases. We estimated the impact of various masking practices on secondary transmission in a cohort of K-12 schools.

methodsWe performed a multistate, prospective, observational, open cohort study from July 26, 2021 to December 13, 2021. Districts reported mitigation practices and weekly infection data. Districts that were able to perform contact tracing and adjudicate primary and secondary infections were eligible for inclusion. To estimate the impact of masking on secondary transmission, we used a quasi-Poisson regression model.

resultsA total of 1 112 899 students and 157 069 staff attended 61 K-12 districts across 9 states that met inclusion criteria. The districts reported 40 601 primary and 3085 secondary infections. Six districts had optional masking policies, 9 had partial masking policies, and 46 had universal masking. In unadjusted analysis, districts that optionally masked throughout the study period had 3.6 times the rate of secondary transmission as universally masked districts; and for every 100 community-acquired cases, universally masked districts had 7.3 predicted secondary infections, whereas optionally masked districts had 26.4.

conclusionsSecondary transmission across the cohort was modest (<10% of total infections) and universal masking was associated with reduced secondary transmission compared with optional masking.

Indexed as

CoinfectionCOVID-19Cohort StudiesHumansPandemicsPolicyProspective StudiesSARS-CoV-2Schools

Identifiers

PMID35260896
PMCPMC9647584
OpenAlexW4220691325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.